VEGFR and type-V RTK activation and signaling

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Biology

Background:

• Vascular endothelial growth factor receptors (VEGFRs) are crucial for angiogenesis and lymphangiogenesis.
• VEGFRs are receptor-type tyrosine kinases (RTKs) with seven immunoglobulin (Ig)-like domains, a transmembrane domain, and a tyrosine kinase domain.
• VEGFRs are structurally related to M-colony stimulating factor receptor/platelet-derived growth factor receptor (CSFR/PDGFR) families, differing in signal transduction pathways.

Purpose of the Study:

• To elucidate the structural and functional characteristics of VEGFRs.
• To compare VEGFR signaling pathways with related RTKs.
• To highlight the role of VEGFRs in pathological angiogenesis and their potential as therapeutic targets.

Main Methods:

• Structural analysis of VEGFRs and related RTKs.
• Phylogenetic analysis to trace the evolutionary origins of VEGFRs.
• Investigation of VEGFR signaling pathways, including PLC-γ-PKC-MAPK and PI3 kinase-Ras-MAPK.

Main Results:

• VEGFRs possess a distinct structure with seven Ig-like domains, differentiating them from the five Ig-like domains of CSFR/PDGFRs.
• VEGFR2, a key mediator of angiogenesis, utilizes the PLC-γ-PKC-MAPK pathway, unlike the PI3 kinase-Ras-MAPK pathway used by CSFR/PDGFRs for cell proliferation.
• Phylogenetic data suggest a VEGFR-like receptor as an ancestral form for both 7 Ig- and 5 Ig-RTK families.

Conclusions:

• VEGFRs play a significant role in vertebrate angiogenesis and lymphangiogenesis.
• Differences in signaling pathways between VEGFRs and CSFR/PDGFRs highlight their distinct biological functions.
• Targeting VEGFRs offers a promising strategy for therapeutic intervention in diseases characterized by pathological angiogenesis, such as cancer and inflammation.